Sign in

CIK 0001652130 · Large accelerated filer

Intellia Therapeutics, Inc.

Sign in to watch
Ticker
NTLA
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
364785571
Phone
857-285-6200
Business address
400 TECHNOLOGY SQUARE, SUITE 100, CAMBRIDGE, MA
  1. 424B5 Offering Prospectus
  2. 424B5 Offering Prospectus
  3. 424B5 Offering Prospectus
  4. 424B5 Offering Prospectus
  5. 424B5 Offering Prospectus
  6. 424B5 Offering Prospectus
  7. 424B5 Offering Prospectus
  8. 424B5 Offering Prospectus
  9. 424B5 Offering Prospectus
  10. 424B5 Offering Prospectus
  11. 424B5 Offering Prospectus
  12. 424B5 Offering Prospectus
  13. 424B5 Offering Prospectus
  14. CORRESP Other Correspondence Between Filers and SEC Staff
  15. CORRESP Other Correspondence Between Filers and SEC Staff
  16. S-3/A Offering Registration Statement
  17. UPLOAD Other SEC-generated Letter
  18. S-3 Offering Registration Statement
  19. CORRESP Other Correspondence Between Filers and SEC Staff
  20. UPLOAD Other SEC-generated Letter

Page 1 of 3 · 42 filings